CDK2 and neoplasm: This mechanism, particularly pronounced during the S-phase of the cell cycle, activates CDK2, enhancing its interaction with DNA polymerase δ.437 An oncogenic role for CDK5 has been observed in breast, lung and pancreatic cancer, while in gastric cancer it might act as tumor suppressor.